Stay updated on Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page
- Check2 days agoChange DetectedA sitewide notice about NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” appears above the study record.SummaryDifference0.7%

- Check9 days agoChange DetectedThe website’s displayed revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check37 days agoChange DetectedThe record history now includes a new revision entry labeled v3.7.0, and the previous revision v3.6.6 is removed from the visible changes, reflecting an updated version in the study's history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record history introduces a new revision entry (v3.6.6) and removes the previous revision (v3.6.5), updating the history to reflect the latest update to the record.SummaryDifference0.1%

- Check79 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history. The previous revision v3.6.4 was removed.SummaryDifference0.1%

Stay in the know with updates to Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page.